NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/22/2025
Back to search
Official data from USPTO
ILOPERA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
11/23/2025
Classification
Registered
Trademark type
Combined
Nice classes
5
Filing date
01/11/2017
Registration date
03/06/2018
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/20/2024
Last transaction
11/23/2025
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
5
Owner type
09
Owner location
TR
Examiner
MICKLEBURGH,LINDA BOHANNON
Law office
L60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
GEN ILAÇ VE SAGLIK ÜRÜNLERI SANAYI VE TICARET ANONIM SIRKETI
Representatives
Halime Evrim HAMAMCIOGLU
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceuticalsmedical and veterinary preparations for improving exercise capacity and symptoms in NYHA III and IV patients with Primary (idiopathic and familial) pulmonary hypertension and with Pulmonary hypertension due to scleroderma without co-existing interstitial pulmonary and for treatment of patients with advanced Thromboangitis obliterans (Buerger's disease) with critical limb ischemia in whom revascularization is not indicatedtreatment of patients with severe peripheral arterial occlusive disease (PAOD)particularly in cases who carry a risk of amputation or cannot undergo angioplastytreatment of patients with Raynaud's phenomenon irresponsive to other treatments and causing severe restriction; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary medical usefood for babies; dietary supplements for humans and animals; medical plastersmaterials for medical dressings; material for stopping teethdental wax; disinfectants; preparations for destroying vermin; fungicidesherbicides
Publications
History of USPTO decisions and trademark events.
31 publications found
INNT
TOTAL INVALIDATION PROCESSED BY THE IB
10/18/2025
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
09/19/2025
XXCR
GENERIC MADRID TRANSACTION CREATED
09/19/2025
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
05/20/2025
C71T
CANCELLED SECTION 71
09/20/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/31/2018
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
06/12/2018
XXCR
GENERIC MADRID TRANSACTION CREATED
06/12/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/06/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
03/06/2018
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
02/15/2018
PUBO
PUBLISHED FOR OPPOSITION
12/19/2017
GPNX
NOTIFICATION PROCESSED BY IB
12/15/2017
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/29/2017
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/29/2017
NPUB
NOTICE OF PUBLICATION
11/29/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/15/2017
ACEC
AMENDMENT FROM APPLICANT ENTERED
10/30/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/30/2017
ALIE
ASSIGNED TO LIE
10/25/2017
PAPER RECEIVED
10/13/2017
RFNT
REFUSAL PROCESSED BY IB
05/05/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/13/2017
RFRR
REFUSAL PROCESSED BY MPU
04/13/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/12/2017
CNRT
NON-FINAL ACTION WRITTEN
04/11/2017
DOCK
ASSIGNED TO EXAMINER
04/04/2017
MAFR
APPLICATION FILING RECEIPT MAILED
03/31/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/27/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/23/2017
Continuous trademark protection
Get notified about every new filing that threatens ILOPERA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.